These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22435599)

  • 1. Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
    Zhang Y; Clark JA; Connelly MC; Zhu F; Min J; Guiguemde WA; Pradhan A; Iyer L; Furimsky A; Gow J; Parman T; El Mazouni F; Phillips MA; Kyle DE; Mirsalis J; Guy RK
    J Med Chem; 2012 May; 55(9):4205-19. PubMed ID: 22435599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead optimization of antimalarial propafenone analogues.
    Lowes D; Pradhan A; Iyer LV; Parman T; Gow J; Zhu F; Furimsky A; Lemoff A; Guiguemde WA; Sigal M; Clark JA; Wilson E; Tang L; Connelly MC; Derisi JL; Kyle DE; Mirsalis J; Guy RK
    J Med Chem; 2012 Jul; 55(13):6087-93. PubMed ID: 22708838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
    Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
    J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
    Nilsen A; Miley GP; Forquer IP; Mather MW; Katneni K; Li Y; Pou S; Pershing AM; Stickles AM; Ryan E; Kelly JX; Doggett JS; White KL; Hinrichs DJ; Winter RW; Charman SA; Zakharov LN; Bathurst I; Burrows JN; Vaidya AB; Riscoe MK
    J Med Chem; 2014 May; 57(9):3818-34. PubMed ID: 24720377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis.
    Li J; Li S; Bai C; Liu H; Gramatica P
    J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.
    Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE
    Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
    Cross RM; Flanigan DL; Monastyrskyi A; LaCrue AN; Sáenz FE; Maignan JR; Mutka TS; White KL; Shackleford DM; Bathurst I; Fronczek FR; Wojtas L; Guida WC; Charman SA; Burrows JN; Kyle DE; Manetsch R
    J Med Chem; 2014 Nov; 57(21):8860-79. PubMed ID: 25148516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration.
    Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP
    J Infect Dis; 2016 Sep; 214(5):753-61. PubMed ID: 27252475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.
    Nagle A; Wu T; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Liu B; Hollenbeck T; Tuntland T; Isbell J; Chuan T; Alper PB; Fischli C; Brun R; Lakshminarayana SB; Rottmann M; Diagana TT; Winzeler EA; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2012 May; 55(9):4244-73. PubMed ID: 22524250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the Optimization of 4(1
    Brockmeyer F; Manetsch R
    Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AQ-13 - an investigational antimalarial drug.
    Mengue JB; Held J; Kreidenweiss A
    Expert Opin Investig Drugs; 2019 Mar; 28(3):217-222. PubMed ID: 30577704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
    Neelarapu R; Maignan JR; Lichorowic CL; Monastyrskyi A; Mutka TS; LaCrue AN; Blake LD; Casandra D; Mashkouri S; Burrows JN; Willis PA; Kyle DE; Manetsch R
    J Med Chem; 2018 Feb; 61(4):1450-1473. PubMed ID: 29215279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoline hybrids and their antiplasmodial and antimalarial activities.
    Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
    Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Sato A; Hiramoto A; Morita M; Matsumoto M; Komich Y; Nakase Y; Tanigawa N; Hiraoka O; Hiramoto K; Hayatsu H; Higaki K; Kawai S; Masuyama A; Nojima M; Wataya Y; Kim HS
    Parasitol Int; 2011 Sep; 60(3):270-3. PubMed ID: 21501696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of antimalarial 4-oxo-3-carboxyl quinolones.
    Zhang Y; Guiguemde WA; Sigal M; Zhu F; Connelly MC; Nwaka S; Guy RK
    Bioorg Med Chem; 2010 Apr; 18(7):2756-66. PubMed ID: 20206533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum.
    Feng LS; Xu Z; Chang L; Li C; Yan XF; Gao C; Ding C; Zhao F; Shi F; Wu X
    Med Res Rev; 2020 May; 40(3):931-971. PubMed ID: 31692025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
    Cross RM; Monastyrskyi A; Mutka TS; Burrows JN; Kyle DE; Manetsch R
    J Med Chem; 2010 Oct; 53(19):7076-94. PubMed ID: 20828199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
    Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
    Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
    J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.